Cytokinetics, Incorporated
CYTK
$59.62
-$0.41-0.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.80% | 51.58% | 75.01% | 87.61% | 86.80% |
| Total Receivables | -- | 141.25% | 1,197.74% | -90.24% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 81.21% | -16.32% | 27.90% | -66.13% | -43.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.98% | 49.69% | 76.41% | 81.43% | 82.04% |
|
|
|||||
| Total Current Assets | -16.98% | 49.69% | 76.41% | 81.43% | 82.04% |
| Net Property, Plant & Equipment | 2.38% | -1.08% | -4.58% | -9.63% | -9.60% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 89.52% | 62.49% | -3.64% | -5.64% | -7.91% |
| Total Assets | -19.57% | 56.43% | 70.04% | 93.90% | 95.38% |
|
|
|||||
| Total Accounts Payable | 71.36% | 7.52% | -5.29% | -16.06% | -24.61% |
| Total Accrued Expenses | 31.40% | 8.06% | 29.74% | 51.20% | 26.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.18% | 9.36% | 9.76% | 76.24% | 91.24% |
| Total Finance Division Other Current Liabilities | 21.60% | 1,061.96% | 486.99% | 31.24% | 298.76% |
| Total Other Current Liabilities | 21.60% | 1,061.96% | 486.99% | 31.24% | 298.76% |
| Total Current Liabilities | 27.52% | 79.76% | 74.99% | 41.29% | 56.63% |
|
|
|||||
| Total Current Liabilities | 27.52% | 79.76% | 74.99% | 41.29% | 56.63% |
| Long-Term Debt | 31.60% | 26.04% | 26.54% | 25.30% | 5.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.87% | -4.39% | -6.51% | -6.42% | -6.22% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.47% | 26.29% | 25.26% | 24.93% | 76.37% |
| Total Liabilities | 12.66% | 27.09% | 26.96% | 22.94% | 27.15% |
|
|
|||||
| Common Stock & APIC | 5.13% | 40.11% | 48.56% | 64.72% | 65.15% |
| Retained Earnings | -25.36% | -27.37% | -27.91% | -29.18% | -29.54% |
| Treasury Stock & Other | 84.54% | 386.64% | 24,080.00% | 716.36% | 29.90% |
| Total Common Equity | -439.68% | 32.75% | 64.96% | 96.83% | 132.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -439.68% | 32.75% | 64.96% | 96.83% | 132.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -439.68% | 32.75% | 64.96% | 96.83% | 132.59% |
|
|
|||||